Article Sidebar

PDF
Date Published: 20/08/2022
Online Published: 20/08/2022
Abstract Views: 329
Views PDF: 179
DOI: https://doi.org/10.58490/ctump.2022i50.135
Issue
No. 50 (2022)
Section
Article
How to Cite
Tran, T. H. A., Tran, N. D., & Nguyen, T. T. T. (2022). RESULTS OF TREATMENT BY E-PSORA (PHA, JOJOBA OIL, VITAMIN E) OF CHRONIC ATOPIC DERMATITIS PATIENTS AT CAN THO DERMATO-VENEREOLOGY HOSPITAL AND CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2020-2022. Cantho Journal of Medicine and Pharmacy, 50, 136-143. https://doi.org/10.58490/ctump.2022i50.135 (Original work published 2022)

RESULTS OF TREATMENT BY E-PSORA (PHA, JOJOBA OIL, VITAMIN E) OF CHRONIC ATOPIC DERMATITIS PATIENTS AT CAN THO DERMATO-VENEREOLOGY HOSPITAL AND CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL IN 2020-2022

Thi Hung An Tran1,, Ngoc Dung Tran1, Thi Thuy Trang Nguyen1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Atopic dermatitis is a chronic inflammatory skin disease that affects people of all ages. The mainstay of treatment for chronic atopic dermatitis is regular usage of topical moisturizers. E-PSORA contains PHA, jojoba oil, and vitamin E with antioxidant, anti-inflammatory and moisturizing propertie which have potential benefits in topical atopic dermatitis treatment. Objectives: To evaluate the results of treatment on chronic atopic dermatitis patients at Can Tho Dermato-Venereology Hospital and Can Tho University of Medicine and Pharmacy Hospital in 2020-2022. Material and methods: A cross-sectional descriptive study was conducted on 100 chronic atopic dermatitis patients, who was treated by E-PSORA within 4 weeks. Evaluate the effect of reducing skin irritation of the drug by SCORAD scale. Results: The results of Scorad scale accouted for: good level 6%, rather good level 74%, medium level 14% and poor level 4%. Side effects have only recongzed itching 12% and skin redness10% in the first week, which disappeared in the next 3 weeks of treatment. Conclusions: E-PSORA can be an good topical therapy in reducing atopic dermatitis lesions for patients.

Article Details

Keywords

E-PSORA, atopic dermatitis, PHA, jojoba oil, vitamin E, Scorad scale

References

1. Phạm Hoàng Khâm (2018), “Kết quả điều trị bệnh viêm da cơ địa mạn tính ở người lớn bằng mỡ tacrolimus 0,1%”, Tạp chí Y Dược học Quân sự, số 5, tr.88-92.
2. Nguyễn Văn Thường (2019), Viêm da cơ địa, Hình ảnh lâm sàng, chẩn đoán và điều trị trong chuyên ngành da liễu tập 1, Nhà xuất bản Y học, tr.33-42.
3. Châu Văn Trở và cs (2013), “Nghiên cứu siêu kháng nguyên của tụ cầu vàng và hiệu quả điều trị viêm da cơ địa bằng kháng sinh cefuroxim”, Luận văn Tiến sĩ Y học, Trường Đại học Y Hà Nội, tr.124-128.
4. Amelia Licari (2017), “A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.”, Minerva Pediatr, 69(6), pp.470-475.
5. Consensus Report of the European Task Force on Atopic Dermatitis (1993), Severity scoring of atopic dermatitis: the SCORAD index, Dermatology, 186(1), pp.23-31.
6. Finberg MJ, Muntingh GL, van Rensburg CE (2015), “A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice”, Inflammopharmacology, 23(6), 337-41.
7. Hon KL (2018), “Emollient treatment of atopic dermatitis: latest evidence and clinical considerations”, Drugs in Context.
8. Shiri, J. C, Assi, A. C, Arnon D (2011), “An open-label study of herbal topical medication (Psirelax) for patients with chronic plaque psoriasis”, Science World Journal, 6(4), pp.13-16.
9. Uehara M.,Sugiura H., m. Omoto (2009), Paternal and maternal atopic dermatitis have the same influencevon development of the disease in children, Acta dermato-venereologica, 79(3), pp.235